Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
RABEPRAZOLE SODIUM
Imbat Limited
A02BC04
RABEPRAZOLE SODIUM
20 Milligram
Tablets Gastro-Resistant
Product subject to prescription which may be renewed (B)
Proton pump inhibitors
Authorised
2007-05-25
_Page 1 of 2 _ PACKAGE LEAFLET: INFORMATION FOR THE USER PARIET ® 20MG GASTRO-RESISTANT TABLETS (rabeprazole sodium) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Pariet is and what it is used for 2. Before you take Pariet 3. How to take Pariet 4. Possible side effects 5. How to store Pariet 6. Further information 1. WHAT PARIET IS AND WHAT IT IS USED FOR Pariet tablet contains the active ingredient rabeprazole sodium. This belongs to a group of medicines called ‘Proton Pump Inhibitors’ (PPIs). They work by lowering the amount of acid that your stomach produces. Pariet tablets are used to treat the following conditions: ‘Gastro-oesophageal reflux disease’ (GORD), which can include heartburn. GORD is caused when acid and food from your stomach escapes into your food pipe (oesophagus) Ulcers in your stomach or the upper part of your gut (intestine). If these ulcers are infected with bacteria called ‘Helicobacter pylori’ (H. Pylori), you will also be given antibiotics. Using Pariet tablets and antibiotics together gets rid of the infection and makes the ulcer heal. It also stops the infection and ulcer from coming back Zollinger-Ellison Syndrome where your stomach produces too much acid Preberite celoten dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PARIET 20mg gastro-resistant tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 20 mg rabeprazole sodium equivalent to 18.85mg rabeprazole. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gastro-resistant tablets _Product imported from Germany:_ Yellow, film-coated biconvex tablet, with ‘E 243’ printed on one side and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pariet tablets are indicated for the treatment of: • active duodenal ulcer • active benign gastric ulcer • symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD) • Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance) • symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD) • Zollinger-Ellison Syndrome In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults/elderly: _Active Duodenal Ulcer and Active Benign Gastric Ulcer_: The recommended oral dose for both active duodenal ulcer and active benign gastric ulcer is 20 mg to be taken once daily in the morning. Most patients with active duodenal ulcer heal within four weeks. However a few patients may require an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcer heal within six weeks. However again a few patients may require an additional six weeks of therapy to achieve healing. _Erosive or Ulcerative Gastro-Oesophageal Reflux Disease (GORD)_: The recommended oral dose for this condition is 20 mg to be taken once daily for four t Preberite celoten dokument